Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 3, 1996, Pages 259-262

  Radloff, Paul D ^a,b   Philipps, Jorg ^a   Nkeyi, Marcel ^a   Sturchler, Dieter ^c   Mittelholzer, Marie Luise ^c   Kremsner, Peter G ^a,d  

^a ALBERT SCHWEITZER HOSPITAL   (Gabon)

^b UNIVERSITY OF VIENNA   (Austria)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEFLENE; MEFLOQUINE;

ANTIMALARIAL ACTIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG RESISTANCE; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ARTABOTRYS; ARTABOTRYS UNCINATUS; PLASMODIUM FALCIPARUM;

EID: 0029743665     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.259     Document Type: Article

References (12)

1. World Health Organization, 1994. World malaria situation in 1992. Wkly Epidemiol Rec 42: 309-332.
2. White NJ, 1992. Antimalarial drug resistance: the pace quickens. J Antimicrob Chemother 30: 571-585.
3. Jaquet C, Stohler HR, Chollet J, Peters W, 1994. Antimalarial activity of the bicyclic peroxide Ro 42-1611 (arteflene) in experimental models. Trop Med Parasitol 45: 266-271.
4. Weidekamm E, Dumont E, Jaquet C, 1994. Tolerability and pharmacokinetics of Ro 42-1611 (arteflene) in man. Trop Med Parasitol 45: 278-283.
5. Salako LA, Guiguemde R, Mittelholzer M-L, Haller L, Sorenson F, Sturchler D, 1994. Ro 42-1611 in the treatment of patients with mild malaria: a clinical trial in Nigeria and Burkina Faso. Trop Med Parasitol 45: 284-287.
6. Somo-Moyou R, Mittelholzer M-L, Sorenson F, Haller L, Sturchler D, 1994. Efficacy of Ro 42-1611 (arteflene) in the treatment of patients with mild malaria: a clinical trial in Cameroon. Trop Med Parasitol 45: 288-291.
7. Winkler S, Brandts C, Wernsdorfer WH, Graninger W, Bienzle U, Kremsner PG, 1994. Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials. Trop Med Parasitol 45: 214-218.
8. Wildling E, Winkler S, Kremsner PG, Brandts C, Jenne L, Wernsdorfer WH, 1995. Malaria epidemiology in the province of Moyen Ogooue, Gabon. Trop Med Parasitol 46: 77-82.
9. Wernsdorfer WH, McGregor I, 1988. Malaria: Principles and Practice of Malariology. Edinburgh: Churchill Livingstone.
10. World Health Organization, 1973. Chemotherapy of malaria and resistance to antimalarials. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 529: 30-35.
11. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W, 1994. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis 169: 467-470.
12. Kremsner PG, Winkler S, Brandts C, Graninger W, Bienzle U, 1993. Curing of chloroquine-resistant malaria with clindamycin. Am J Trop Med Hyg 49: 650-654.